The Azuriya identity
The brand has to communicate two things at once: the precision of a serious clinical team, and the ambition of a company that thinks inflammation can be reset at its molecular thermostat. This page is the working reference for doing that consistently.
Anyone producing externally-facing Azuriya materials — slide decks, the website, investor one-pagers, scientific posters, contract collateral, social, and press. Follow these rules by default; deviations require CEO sign-off.
Brand pillars
- Precise. Name the mechanism, cite the number, reference the trial. Avoid adjectives where a datum will do.
- Reserved. We describe what has been observed in the data we have. We do not extrapolate. Hedge language — observed, supports, suggests — is appropriate in preclinical and early-clinical contexts.
- Ambitious. A small flourish — the gradient, a single italic phrase — signals that this is not a me-too program. Used sparingly.
The logo
The Azuriya mark is composed of three elements: the indigo wordmark, the emerald arc, and the violet→magenta gradient underline. The three are designed to be seen together. The arc reads as forward motion; the gradient underline as a pulse of signal. The wordmark carries the institutional weight.
Backgrounds
Clear space & minimum size
Maintain clear space on all four sides of the mark equal to the cap-height of the letter A in "Azuriya". Never allow other content — images, text, graphic elements, page edges — to enter this zone.
- Digital: minimum 120 px wide. Below this the gradient underline becomes indistinct.
- Print: minimum 1.0 in / 25 mm wide.
- Favicon / app icons: use the isolated emerald arc on an indigo square. Full wordmark is not used below 64 px.
Usage rules
✓ Do
- Keep the three elements together and in their specified proportions.
- Use the reversed (white wordmark) version on ink and indigo backgrounds only.
- Ensure at least 3:1 contrast between the wordmark and its background.
- Preserve clear space equal to the "A" cap-height.
✕ Don't
- Stretch, skew, rotate, or outline the mark.
- Change the color of the wordmark, arc, or gradient.
- Separate the three elements or recompose them.
- Apply drop shadows, glows, bevels, or filters.
- Pair the wordmark with a second logotype in a different typeface.
Color
The palette is pulled directly from the logo. Three families: brand core (indigo, emerald, violet/magenta) for identity; surfaces (cloud, lavender, mint) for backgrounds; neutrals for text and lines. The color balance across any page should skew indigo-first, with emerald and the gradient used as accents rather than fields.
Brand core
Surfaces & neutrals
Signature gradient
Linear, 90° (left to right): #8B4FD8 at 0% → #C850DC at 100%. Used exclusively for the italic highlight phrase in hero H1s, the active-page underline in navigation, the left-border accent on featured callouts, and a single divider element between major sections.
Contrast & accessibility
| Pairing | Sample | Ratio | WCAG |
|---|---|---|---|
| Indigo on White | Aa | 13.4 : 1 | AAA (all sizes) |
| White on Indigo | Aa | 13.4 : 1 | AAA (all sizes) |
| Ink (body) on White | Aa | 16.7 : 1 | AAA (all sizes) |
| Emerald on White | Aa | 4.5 : 1 | AA (normal text) |
| Violet on White | Aa | 4.8 : 1 | Display only (≥ 24 px) |
| Magenta on White | Aa | 3.6 : 1 | Large-text only |
Typography
Two faces carry most of the identity. Fraunces, a variable serif with an optical-size axis, handles display. Manrope, a modern geometric sans, handles body. A monospace — JetBrains Mono — handles the technical spine: compound names, gene symbols, DOI / PMID, NCT numbers.
Type scale (desktop)
Targeting the upstream cause.
A thermostat for inflammation.
Mechanism, not a moment.
Pipeline & patents through 2044+
Four master transcription factors
APX3330 is a late-stage, first-in-class oral small-molecule therapy that modulates APE1/Ref-1 — the master transcription-factor regulator controlling NF-κB, HIF-1α, STAT3, and AP-1.
Safety across four trials in ~400 patients, 600 mg RP2D, zero treatment-related SAEs observed. Composition-of-matter and method-of-use protection through 2044+ across seven patent families.
Phase 2a · Australia · 2026
APX3330 · APE1/Ref-1 · NCT03375086 · DOI 10.1038/s42003-026-09860-z
Mobile & fallbacks
On mobile, display sizes scale down: display-xl → 40 px, display-lg → 32 px, display-md → 26 px; body stays at 15 px with line-heights loosened by +0.05. Web-safe fallbacks if the primary family fails to load: Fraunces → Georgia → serif, Manrope → system-ui → sans-serif, JetBrains Mono → SF Mono → Menlo → monospace.
Voice & messaging
The Azuriya voice is that of a clinical team that respects its audience. It does not oversell. It does not hedge when it has data. It uses the specific word (mechanism, pathway, master regulator) rather than the comforting one (approach, target, key factor).
Write this way
- Specific numbers beat adjectives. "~400 patients dosed across four trials" is better than "extensively studied." "2044+ patent life" is better than "long patent runway."
- Mechanism first. Lead with APE1/Ref-1 inhibition and the four master transcription factors (NF-κB, HIF-1α, STAT3, AP-1). Don't lead with "novel" or "first-in-class" as abstract claims.
- Active voice, short clauses. "APX3330 inhibits APE1/Ref-1" — not "APE1/Ref-1 is inhibited by APX3330 via a redox-regulatory mechanism involving…"
- Name the trial. NCT03375086, ZETA-1, Phase 1 HV (Eisai). Numbers and identifiers are citable.
Approved positioning vs. avoid
✓ Approved positioning
First-in-class oral APE1/Ref-1 inhibitor for inflammatory bowel disease.
Upstream of the four master transcription factors that drive IBD inflammation.
~400 patients dosed across prior clinical studies; 600 mg RP2D; no treatment-related SAEs observed.
Composition-of-matter and method-of-use protection through 2044+ across seven patent families.
✕ Avoid in external copy
"Cure for IBD" · "Guaranteed safety profile" · "Revolutionary" · "Game-changing"
"Better than [branded competitor]" without a direct head-to-head or a clear denominator.
"Platform" applied to a single compound.
Any efficacy claim in UC patients prior to Phase 2a data. Specific deal-value figures for comparables pulled from non-public sources.
Applications
A small set of canonical applications. The reference HTML templates on this site are the source of truth for any digital application — when in doubt, match the page.
Website
Primary application; reference HTML templates are the source of truth for tokens and components.
- Hero sections use the ink→indigo gradient background.
- All other sections use white or cloud.
- Navigation is sticky with a blurred backdrop; active-page indicator is a 2-px gradient underline.
Slide decks
Deck template follows the same tokens as the site.
- Title slides: ink background with knockout logo.
- Body slides: white background, indigo H1 in Fraunces 36 pt, Manrope body 18 pt.
- Data slides: tables use indigo header rows; body rows alternate white and cloud.
Investor materials
- One-pagers use the lavender-tinted card layout with indigo H1 and emerald accent numerics.
- Financials and market sizing shown as mono-typeset values in JetBrains Mono for typographic distinction.
- Safe-harbor / forward-looking disclaimer set in Manrope 9 pt at the foot of every page.
Print & social
- Business cards: 3.5 × 2 in, indigo reverse with knockout logo on front; white with full-color logo on back.
- Letterhead: logo top-left with 1 in margin; footer with a single indigo 1-pt rule above the address.
- Social avatars: isolated emerald arc on indigo square, 400 × 400 px.
Email signature
Standardized signature block for all @azuriyapharma.com addresses:
Design tokens
CSS custom properties published in styles.css. These are the canonical values — anything produced for Azuriya should match.
| Token | Value | Notes |
|---|---|---|
| --indigo | #1C1691 | Primary |
| --indigo-deep | #14107A | Hover / pressed |
| --ink | #0B0A4E | Dark backgrounds |
| --emerald | #00A03C | Secondary accent |
| --emerald-bright | #14BE54 | Hover highlight |
| --violet | #8B4FD8 | Gradient start |
| --magenta | #C850DC | Gradient end |
| --cloud | #F7F8FC | Neutral surface |
| --lavender | #F0EBFA | Corporate tint |
| --mint | #E6F7EC | Science tint |
| --ink-body | #1A1A2E | Body text |
| --ink-muted | #555566 | Secondary text |
| --line | #E4E4F0 | Dividers / borders |
| --f-display | Fraunces, Georgia, serif | Display face |
| --f-sans | Manrope, system-ui, sans-serif | Body face |
| --f-mono | JetBrains Mono, SF Mono, monospace | Technical face |
| --gradient-accent | linear-gradient(90deg, #8B4FD8, #C850DC) | Signature gradient |
Contact [email protected] for approvals on any application outside this guide. Brand updates to this document are logged with version number and date.